Institutional Ownership
Soleno Therapeutics Inc
CUSIP 834203309COMSLNOQ1 2026
13D / 13G Filings
53
Schedule 13D/13G on record
Beneficial Filers
16
Distinct reporting persons
Largest Stake
50.8%
Max % of class reported
Institutional Holders
217
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
53 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Janus Henderson Group PLC | 13G/A | 13.4% | 7.18M | SEC |
| 2 | Feb 17, 2026 | Avoro Capital Advisors LLC | 13G | 5.4% | 2.90M | SEC |
| 3 | Feb 10, 2026 | Wellington Management Group LLP | 13G | 6.2% | 3.32M | SEC |
| 4 | Nov 14, 2025 | Janus Henderson Group PLC | 13G/A | 11.4% | 6.06M | SEC |
| 5 | Nov 14, 2025 | Vivo Opportunity Fund Holdings, L.P. | 13G/A | 4.2% | 2.25M | SEC |
| 6 | Nov 13, 2025 | Adage Capital Management, L.P. | 13G/A | 2.6% | 1.40M | SEC |
| 7 | Oct 31, 2025 | The Vanguard Group | 13G | 5.3% | 2.81M | SEC |
| 8 | Aug 14, 2025 | Janus Henderson Group PLC | 13G/A | 10.5% | 5.31M | SEC |
| 9 | Aug 14, 2025 | Nantahala Capital Management, LLC | 13G/A | 2.0% | 1.00M | SEC |
| 10 | Aug 14, 2025 | Avoro Capital Advisors LLC | 13G/A | 4.1% | 2.05M | SEC |
43 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Soleno Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Janus Henderson Group PLC | 7.10M | $237.63M |
| 2 | Fmr LLC | 5.79M | $193.80M |
| 3 | Wellington Management Group LLP | 4.43M | $148.21M |
| 4 | Blackrock, Inc. | 3.74M | $125.31M |
| 5 | State Street Corp | 2.68M | $89.75M |
| 6 | Avoro Capital Advisors LLC | 2.30M | $77.00M |
| 7 | Nantahala Capital Management, LLC | 1.74M | $58.39M |
| 8 | Polar Capital Holdings PLC | 1.70M | $56.88M |
| 9 | Khrom Capital Management LLC | 1.51M | $50.60M |
| 10 | Geode Capital Management, LLC | 1.24M | $41.44M |